Indeed, MAPK14 is up-regulated in BRAF-inhibition-resistant melanoma in mouse models [98,99], while MAPK11 abrogation promotes radiosensitivity in A549, MCF7, and HCT-116 cells [100]. Here, MAPK14 is linked to melanoma.